Gal-3 concentrations are increased in the brains, CSF and plasma of humans with AD [174,175,176] and Gal-3 brain injections increase insoluble Aβ levels and toxicity in animals [11,177]. The gene discussed is LGALS3; the disease is Alzheimer disease.